For more than eight decades The Jackson Laboratory (JAX) has been a catalyst for the modeling and study of human disease, primarily through research employing genetically well-defined laboratory mice.
The Jackson Laboratory Center for Precision Genetics (JCPG) seeks to extend this tradition using cutting-edge technologies and expertise to develop and disseminate new, precise animal models of incurable and genetically complex human diseases. The effort brings together an international, multi-disciplinary team—including geneticists and genetics technology experts, quantitative and computational biologists, clinical experts in specific disease areas and world leaders in the development of precision animal models of disease. The JCPG was initiated in 2015 as one of three NIH-funded Pilot Centers for Precision Disease Modeling (NIH-1U54OD020351). Efforts at The Jackson Laboratory are complemented by funded centers led by Dr. Ross Cagan at Icahn School of Medicine at Mount Sinaiand Dr. Scott Lowe at Memorial Sloan Kettering Cancer Center.
Conceptual View of the JAX Center for Precision Genetics